Legal Representation
Attorney
Nicole Kinsley, Esq.
USPTO Deadlines
Next Deadline
1528 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-09-19)
Due Date
September 19, 2029
Grace Period Ends
March 19, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 19, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Sep 19, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 30, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jun 30, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jun 30, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jun 30, 2023 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Jun 14, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| May 30, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
| May 26, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| May 24, 2023 | AAUA | E | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| May 23, 2023 | IUAA | P | USE AMENDMENT ACCEPTED |
| May 23, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 21, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 26, 2023 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Dec 21, 2022 | IUAF | S | USE AMENDMENT FILED |
| Dec 21, 2022 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE |
| Dec 20, 2022 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED |
| Dec 6, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Dec 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Nov 17, 2022 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere:
Nov 22, 2022
First Use in Commerce:
Nov 22, 2022
Additional Information
Design Mark
The mark consists of the word "ELAHERE" in block capital letters with the design of a half circle sunburst to the left of "ELAHERE" made up of trapezoid-shaped lines, each divided into three sections of different shades, arrayed around the upper left corner of the first "E" in "ELAHERE".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...